Relative Bioavailability and Food Effect Study of Nilotinib NFE

• Research type

  Research Study

• Full title

  A Study in Healthy Subjects Designed to Assess the Relative Bioavailability of Nilotinib NFE Tablet Formulations Compared to Tasigna® and to Assess the Effect of Food on a Selected Nilotinib NFE Tablet Formulation

• IRAS ID

  1003164

• Contact name

  Litza McKenzie

• Contact email

  Litza.McKenzie@quotientsciences.com

• Eudract number

  2019-004136-29

• Research summary

  Summary of Results
  Given that this is a phase 1 trial, no lay summary of results has been provided for reasons of commercial confidentiality.

• REC name

  HSC REC B

• REC reference

  20/NI/0058

• Date of REC Opinion

  18 Jun 2020

• REC opinion

  Favourable Opinion